Regulation of LPS stimulated ROS production in peritoneal macrophages from alloxan-induced diabetic rats:: Involvement of high glucose and PPARγ

被引:41
作者
de Souza, Luiz Fernando [1 ]
Barreto, Fabiano [1 ]
da Silva, Evandro Gomes [1 ]
Andrades, Michael Everton [1 ]
Guimaraes, Eduardo Linck Machado [1 ]
Behr, Guilherme Antonio [1 ]
Moreira, José Cláudio Fonseca [1 ]
Bernard, Elena Aida [1 ]
机构
[1] Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, RS, Brazil
关键词
lipopolvsaccharide; macrophages; alloxan; hyperglycemia; PPAR; ROS; nitric oxide;
D O I
10.1016/j.lfs.2007.04.035
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
An increased occurrence of long term bacterial infections is common in diabetic patients. Bacterial cell wall components are described as the main antigenic agents from these microorganisms and high blood glucose levels are suggested to be involved in altered immune response. Hyperglycemia is reported to alter macrophages response to lipopolysaccharide (LPS) and peroxisome proliferators activated receptor gamma (PPAR gamma) expression. Additionally, glucose is the main metabolic fuel for reduced nicotinamide adenine dinucleotide phosphate (NADPH) production by pentose phosphate shunt. In this work, lipopolysaccharide (LPS) stimulated reactive oxygen species (ROS) and nitrite production were evaluated in peritoneal macrophages from alloxan-induced diabetic rats. Cytosolic dehydrogenases and PPAR gamma expression were also investigated. LPS was ineffective to stimulate ROS and nitrite production in peritoneal macrophages from diabetic rats, which presented increased glucose-6-phosphate dehydrogenase and malate dehydrogenase activity. In RAW 264.7 macrophages, acute high glucose treatment abolished LPS stimulated ROS production, with no effect on nitrite and dehydrogenase activities. Peritoneal macrophages from alloxan-treated rats presented reduced PPAR gamma expression. Treating RAW 264.7 macrophages with a PPAR gamma antagonist resulted in defective ROS production in response to LPS, however, stimulated nitrite production was unaltered. In conclusion, in the present study we have reported reduced nitric oxide and reactive oxygen species production in LPS-treated peritoneal macrophages from alloxan-induced diabetic rats. The reduced production of reactive oxygen species seems to be dependent on elevated glucose levels and reduced PPAR gamma expression. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:153 / 159
页数:7
相关论文
共 38 条
[1]   Oxidative parameters differences during non-lethal and lethal sepsis development [J].
Andrades, M ;
Ritter, C ;
Moreira, JCF ;
Dal-Pizzol, F .
JOURNAL OF SURGICAL RESEARCH, 2005, 125 (01) :68-72
[2]   PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation [J].
Chawla, A ;
Barak, Y ;
Nagy, L ;
Liao, D ;
Tontonoz, P ;
Evans, RM .
NATURE MEDICINE, 2001, 7 (01) :48-52
[3]   Peroxisome proliferation-activated receptor (PPAR)γ is not necessary for synthetic PPARγ agonist inhibition of inducible nitric-oxide synthase and nitric oxide [J].
Crosby, MB ;
Svenson, JL ;
Zhang, J ;
Nicol, CJ ;
Gonzalez, FJ ;
Gilkeson, GS .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (01) :69-76
[4]   Regulation and termination of NADPH oxidase activity [J].
DeCoursey, TE ;
Ligeti, E .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2005, 62 (19-20) :2173-2193
[5]   Thymoquinone suppresses expression of inducible nitric oxide synthase in rat macrophages [J].
El-Mahmoudy, A ;
Matsuyama, H ;
Borgan, MA ;
Shimizu, Y ;
El-Sayed, MG ;
Minamoto, N ;
Takewaki, T .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2002, 2 (11) :1603-1611
[6]  
Ferret Pierre-Jacques, 2002, BMC Immunol, V3, P3
[7]  
Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189
[8]  
FORSTERMANN U, 1995, N-S ARCH PHARMACOL, V352, P351
[9]   Regulation of nuclear translocation of HDAC3 by IκBα is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor γ function [J].
Gao, ZG ;
He, Q ;
Peng, BL ;
Chiao, PJ ;
Ye, JP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (07) :4540-4547
[10]  
GAULTON GN, 1985, DIABETOLOGIA, V28, P769